ASCO26: Michael Hassett, MD, MPH, eSyM - Report - MDSpire
Advertisement
ASCO26: Michael Hassett, MD, MPH, eSyM
Dr. Michael Hassett of Dana-Farber Cancer Institute shared new findings showing deployment of eSyM, an ePRO-based, EHR-integrated symptom management program, was associated with statistically significant and potentially meaningful improvements in overall survival. Strategies to improve adoption of ePRO-based symptom management may be warranted.
Clinical Report: eSyM Program Associated with Improved Overall Survival
Overview
Deployment of the eSyM, an ePRO-based symptom management program, was linked to statistically significant improvements in overall survival.
Background
The integration of patient-reported outcomes (PROs) into cancer care is increasingly recognized for its potential to enhance patient-centered outcomes. Recent guidelines emphasize the importance of routine symptom monitoring to improve clinical management and patient quality of life.
Data Highlights
No specific numerical data provided in the source material.
Key Findings
eSyM is an electronic patient-reported outcomes (ePRO) program integrated with electronic health records (EHR).
Deployment of eSyM was associated with statistically significant improvements in overall survival.
Guidelines from ESMO recommend the use of PRO measures across the cancer care continuum.
Landmark trials have shown that electronic symptom monitoring can improve overall survival compared to usual care.
Clinical Implications
The findings suggest that implementing ePRO systems like eSyM could be a valuable addition to oncology practices. Clinicians may need to consider strategies for improving the integration and utilization of these systems in routine care.
Conclusion
The association of the eSyM program with improved overall survival requires further exploration.